A parliamentary question has been posed by 46 SYRIZA MPs, asking to be officialy informed by all the competent ministries on their next steps regarding the medical use of cannabis in our country, Greece.
Recently, the Ministry of Health together with the Ministry of Justice issued a joint ministerial decision, with which cannabis and its resin were transferred from Table A to Table B of Law 3459/2006. As stated in the question of SYRIZA MPs, this change in categorization implies that cannabis cultivation, processing and disposal will be conducted only through the state monopoly, putting off procedures other natural or legal entities. Consequently, they state, such a system involves risks and limits potential development prospects in the agricultural sector, in medicinal and rural research and education, as well as it will not be able to effectively respond to patients’ needs.
More specifically, the questions addressed to the Ministers of Health, Justice, Economy and Labour are the following:
When are the ministerial decisions expected to make legal cannabis use in Greece possible under the existing regime?
What will be the insurance coverage for the use of medical cannabis formulations so that their price is accessible to all patients? How will patients be guaranteed a practical prescription status?
Do the competent ministries have the intention to developmentally exploit medical cannabis? If so, how?
Do the competent ministries intend to reform the current legislation in order to enable the production, processing and export of cannabis by natural and legal entities, with state licensing and control through the National Organization for Medicines?
The co-operating organizations for the establishment and co-ordination of the Hellenic Observatory on Medical Use of Cannabis, on the occasion of the signing of the Joint Ministerial Decision between the Ministry of Health and the Ministry of Justice on the transport of cannabis and its resin from Table A of Table B of Law 3459/2006 (Government Gazette 103 A), as amended and in force with law no. 4139/2013 “, issued a letter to the Minister of Health, Mr. Xanthos.
You can read the whole letter here.
“DIOGENIS – Drug Policy Dialogue” www.diogenis.info
“Eleutherian Association of Dependence” (ELEYSYNA) »http://elefsyna.org/
“HELIOSPORI – Network for Social and Political Ecology” http://iliosporoi.net/
“MAMAKA – MAMAs for Kannabe (MAMMAKA)” Association https://www.facebook.com/groups/farmakeftikikannavi/
“Butterfly Effect Cooperative” Network for Social Health http://thebutterflyeffectcooperative.org/
In view of the on-going progress in the field of the medical use of cannabis at international level, as well as the current developments in our country, NGO Diogenis within a network of collaborating civil society organizations – with years of experience, knowledge and activity in this specific area of interest – is undertaking the initiative to set up and coordinate the establishment of the “Greek Observatory for the Medical Use of Cannabis”.
The common goal of our organizations is to ensure the immediate, unhindered and legal access of patients to quality cannabis for medical use based on international evidence based data and best practices.
The issue of Drug Consumption Rooms has been discussed for some time now in Greece, and as a country we have the 10-month experience of such an room in the center of Athens. (“ODYSSEAS” program, 2013-2014). Drug Consumption Rooms have been operating for decades in many countries in Europe and globally, providing important data and conclusions.
It is also important, in our country, that any discussion for this issue, to be done only on the basis of scientifically substantiated data.
You can read here the press release of “Diogenes” on the occasion of the relevant Press Release of KETHEA (30/5/2017).
Publication on the medical website “ygeia360.gr” by journalist Vasilis Venizelos, about the informative meeting on the conclusions of the 60th UN Drugs Committee meeting and their relevance to current drug policy in Greece.